Orthopedic Devices - Benelux | Statista Market Forecast

The projected revenue for the Orthopedic Devices market market in Benelux is estimated to reach US$808.50m in 2024.
It is expected to experience an annual growth rate (CAGR 2024-2029) of 2.86%, leading to a market volume of US$930.90m by 2029.
When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$16.02bn in 2024.
The orthopedic devices market in Benelux is experiencing a surge in demand due to the region's aging population and increasing prevalence of musculoskeletal disorders.

Definition:
The Orthopedic Devices market contains medical equipment and accessories used to treat orthopedic disorders, including joint reconstruction, spinal devices, trauma fixation devices, arthroscopic devices, etc.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Johnson & Johnson, Zimmer Biomet, Stryker, Medtronic. Further information on the key players can be found in the Market Shares boxes.

Joint reconstruction implants
Spinal devices
Trauma fixation devices
Arthroscopy devices

Orthopedic pharmaceuticals
Orthopedic supplements

The Orthopedic Devices market in Benelux is experiencing steady growth due to various factors such as an aging population, increasing prevalence of orthopedic disorders, and advancements in medical technology.

Customer preferences: Customers in the Benelux region are increasingly opting for orthopedic devices to improve their quality of life and maintain mobility. With a growing elderly population, there is a higher demand for joint replacement surgeries and orthopedic implants. Patients are also seeking minimally invasive procedures and personalized treatment options that offer faster recovery times and better outcomes. Additionally, there is a rising awareness about the benefits of orthopedic devices in managing chronic conditions such as osteoarthritis and osteoporosis.

Trends in the market: One major trend in the Benelux orthopedic devices market is the adoption of innovative technologies. Surgeons are increasingly using robotic-assisted systems for joint replacement surgeries, which offer greater precision and accuracy. This trend is driven by the need for better patient outcomes and reduced surgical complications. Another trend is the development of bioresorbable implants, which are gradually replacing traditional metallic implants. These implants are designed to gradually dissolve in the body, eliminating the need for additional surgeries for implant removal.

Local special circumstances: The Benelux region consists of three countries - Belgium, the Netherlands, and Luxembourg - each with its own unique healthcare system and regulations. This can result in variations in the adoption of orthopedic devices and reimbursement policies across the region. Additionally, the Benelux region has a high concentration of medical device manufacturers, which contributes to the availability of a wide range of orthopedic devices in the market.

Underlying macroeconomic factors: The growth of the orthopedic devices market in Benelux is supported by favorable macroeconomic factors. The region has a stable economy and a well-developed healthcare infrastructure, which enables access to advanced medical technologies. Additionally, the governments in the Benelux countries are investing in healthcare and research and development, which further drives the growth of the orthopedic devices market. The presence of a skilled workforce and academic institutions also contributes to the development and adoption of innovative orthopedic technologies in the region. Overall, the Orthopedic Devices market in Benelux is poised for continued growth due to the increasing demand for orthopedic treatments, advancements in technology, and favorable macroeconomic factors. With the aging population and rising prevalence of orthopedic disorders, the market is expected to witness further expansion in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.